Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-01-09 09:07 am Purchase |
2023-12-31 | 13G | Elevation Oncology, Inc. ELEV |
Empery Asset Management, LP | 4,000,000 6.700% |
4,000,000 (New Position) |
Filing History |
| 2024-01-09 09:06 am Purchase |
2023-12-31 | 13G | Sharps Technology, Inc. STSS |
Empery Asset Management, LP | 241,636 9.990% |
241,636 (New Position) |
Filing History |
| 2024-01-09 09:05 am Purchase |
2023-12-31 | 13G | SOBR Safe, Inc. SOBR |
Empery Asset Management, LP | 10,924 6.090% |
10,924 (New Position) |
Filing History |
| 2024-01-09 09:03 am Purchase |
2023-12-31 | 13G | Nuvve Holding Corp. NVVE |
Empery Asset Management, LP | 11,260 9.990% |
11,260 (New Position) |
Filing History |
| 2024-01-08 10:26 am Sale |
2023-12-31 | 13G | X4 Pharmaceuticals, Inc. XFOR |
Empery Asset Management, LP | 4,549,605 2.650% |
-1,649,079 (-26.60%) |
Filing History |
| 2024-01-08 10:25 am Unchanged |
2023-12-31 | 13G | Kiromic BioPharma, Inc. KRBP |
Empery Asset Management, LP | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2024-01-08 10:23 am Purchase |
2023-12-31 | 13G | RedHill Biopharma Ltd. RDHL |
Empery Asset Management, LP | 414,607 3.190% |
414,607 (New Position) |
Filing History |
| 2024-01-08 10:22 am Purchase |
2023-12-31 | 13G | Permex Petroleum Corporation OILCF |
Empery Asset Management, LP | 52,083 4.990% |
52,083 (New Position) |
Filing History |
| 2023-01-13 08:04 am Purchase |
2022-12-31 | 13G | RedHill Biopharma Ltd. RDHL |
Empery Asset Management, LP | 6,200 6.120% |
6,200 (New Position) |
Filing History |
| 2023-01-13 08:02 am Purchase |
2022-12-31 | 13G | X4 Pharmaceuticals, Inc. XFOR |
Empery Asset Management, LP | 6,198,684 5.120% |
6,198,684 (New Position) |
Filing History |
| 2023-01-13 08:00 am Purchase |
2022-12-31 | 13G | Volcon, Inc. VLCN |
Empery Asset Management, LP | 67 9.990% |
67 (New Position) |
Filing History |
| 2023-01-12 10:03 am Purchase |
2022-12-31 | 13G | Permex Petroleum Corporation OILCF |
Empery Asset Management, LP | 13,021 9.580% |
13,021 (New Position) |
Filing History |
| 2023-01-12 10:02 am Purchase |
2022-12-31 | 13G | Kiromic BioPharma, Inc. KRBP |
Empery Asset Management, LP | 163,268 9.990% |
163,268 (New Position) |
Filing History |
| 2023-01-12 10:01 am Unchanged |
2022-12-31 | 13G | Direct Digital Holdings, Inc. DRCT |
Empery Asset Management, LP | 270,000 4.990% |
0 (Unchanged) |
Filing History |
| 2023-01-12 10:01 am Sale |
2022-12-31 | 13G | iSpecimen Inc. ISPC |
Empery Asset Management, LP | 21,875 4.680% |
-1,442 (-6.18%) |
Filing History |
| 2022-03-18 5:15 pm Purchase |
2022-02-10 | 13G | Direct Digital Holdings, Inc. DRCT |
Empery Asset Management, LP | 270,000 9.640% |
270,000 (New Position) |
Filing History |
| 2022-01-24 10:35 am Sale |
2021-12-31 | 13G | Titan Pharmaceuticals, Inc. TTNP |
Empery Asset Management, LP | 43,022 4.990% |
-4,206 (-8.91%) |
Filing History |
| 2022-01-24 10:33 am Purchase |
2021-12-31 | 13G | Kiora Pharmaceuticals, Inc. KPRX |
Empery Asset Management, LP | 1,484 4.050% |
1,484 (New Position) |
Filing History |
| 2022-01-24 10:32 am Purchase |
2021-12-31 | 13G | iSpecimen Inc. ISPC |
Empery Asset Management, LP | 23,317 5.340% |
23,317 (New Position) |
Filing History |
| 2022-01-24 10:30 am Purchase |
2021-12-31 | 13G | Polished.com Inc. POL |
Empery Asset Management, LP | 168,985 4.990% |
35,653 (+26.74%) |
Filing History |